Browse by Title

All times listed are Central Daylight Time. Program and Faculty are updated often – check back for the most up-to-date information. Click on session name to view session description and component talks.

Browse by Title

Type here to filter the list

L
Landscape of Primary Antiphospholipid Syndrome: Clinical Spectrum, Serology, and Predictors of Damage in a Single Center Cohort of 233 Patients (0137)

Ritesh Kumar Mishra, MD – JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH ### 2762437###Abstract Poster Presenter######JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH###
Abstract Poster Presenter: Ritesh Kumar Mishra, MD – JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH
### 0137
Latent Class Analysis Identifies Distinct Phenotypes of Multisystem Immune-Related Adverse Events Predictive of Survival After Immune Checkpoint Inhibitors (1121)

Tao Ming Sim, MBBS – National University Hospital ### 2763067###Abstract Poster Presenter######National University Hospital###
Abstract Poster Presenter: Tao Ming Sim, MBBS – National University Hospital
### 1121
Latent Class Analysis Identifies Distinct Phenotypes of Multisystem Immune-Related Adverse Events Predictive of Survival After Immune Checkpoint Inhibitors (1121)

Tao Ming Sim, MBBS – National University Hospital ### 2763067###Abstract Poster Presenter######National University Hospital###
Abstract Poster Presenter: Tao Ming Sim, MBBS – National University Hospital
### 1121
Latent Profiles of Parenchymal Abnormalities and Vascular Features Measured by Quantitative CT Identifies a Subgroup of Systemic Sclerosis Patients With a Greater Lung Function Decline Over Time (1556)

Alicia Hinze, MD, MHS – Mayo Clinic - Rochester, MN ### 1426696###Abstract Poster Presenter######Mayo Clinic - Rochester, MN###
Abstract Poster Presenter: Alicia Hinze, MD, MHS – Mayo Clinic - Rochester, MN
### 1556
Launch of the National Tele-Rheumatology Program (NTRP) to Expand Rheumatology Care to Rural Veterans (0181)

Cherish Wilson, BA – UCSF / SFVA ### 2107256###Abstract Poster Presenter######UCSF / SFVA###
Abstract Poster Presenter: Cherish Wilson, BA – UCSF / SFVA
### 0181
LBL-047, A First-In-Class Anti-BDCA2/TACI Fusion Protein, Inhibits the Function of Both pDCs and B cells (0005)

Hong Ling, n/a – Nanjing Leads Biolabs Co., Ltd. ### 2762400###Abstract Poster Presenter######Nanjing Leads Biolabs Co., Ltd.###
Abstract Poster Presenter: Hong Ling, n/a – Nanjing Leads Biolabs Co., Ltd.
### 0005
LBL-053, A Novel Anti-TL1A/p40 Bispecific Antibody for the Treatment of Autoimmune Disorders. (0986)

Hong Ling, n/a – Nanjing Leads Biolabs Co., Ltd. ### 2762400###Abstract Poster Presenter######Nanjing Leads Biolabs Co., Ltd.###
Abstract Poster Presenter: Hong Ling, n/a – Nanjing Leads Biolabs Co., Ltd.
### 0986
LBL-057, a Novel ADCC Enhanced PD-1 Agonist VHH-Fc Antibody (1001)

Xiao Huang, MS – Leads Biolabs ### 2762399###Abstract Poster Presenter######Leads Biolabs###
Abstract Poster Presenter: Xiao Huang, MS – Leads Biolabs
### 1001
Levels of Disease Activity and Their Relationship With Health-Related Quality of Life In ANCA-Associated Vasculitis Patients: Data from the Almenara Vasculitis Cohort (0730)

Victor Pimentel-Quiroz, MD (he/him/his) – Universidad Científica del Sur ### 1422343###Abstract Poster Presenter######Universidad Científica del Sur###
Abstract Poster Presenter: Victor Pimentel-Quiroz, MD (he/him/his) – Universidad Científica del Sur
### he/him/his 0730
Leveraging Natural Language Processing to Uncover Real-World Trends in Cannabis Use from Clinic Notes in Electronic Health Records (1086)

Titilola Falasinnu, PhD – Stanford School of Medicine ### 1302703###Abstract Poster Presenter######Stanford School of Medicine###
Abstract Poster Presenter: Titilola Falasinnu, PhD – Stanford School of Medicine
### 1086
Leveraging Social Risk Factor Screening Infrastructure in Rheumatology Clinics to Respond to Rising Rates of Tuberculosis Among Individuals Experiencing Homelessness (1057)

Candace Feldman, MD, MPH, ScD – Brigham and Women's Hospital ### 838944###Abstract Poster Presenter######Brigham and Women's Hospital###
Abstract Poster Presenter: Candace Feldman, MD, MPH, ScD – Brigham and Women's Hospital
### 1057
Leveraging the Electronic Medical Record to Improve the Rate of Discrete Data Collection in a Pediatric Rheumatology Clinic (0229)

Lisa Buckley, MD – Vanderbilt University Medical Center ### 1423071###Abstract Poster Presenter######Vanderbilt University Medical Center###
Abstract Poster Presenter: Lisa Buckley, MD – Vanderbilt University Medical Center
### 0229
LEVI-04, a Novel Neurotrophin-3 Inhibitor, Demonstrates Clinically Meaningful Improvements in Pain and Physical Function across a Range of OA Outcomes, Including the Staircase-Evoked Pain Procedure (StEPP) (2101)

Philip Conaghan, MD,PhD – University of Leeds ### 839024###Abstract Poster Presenter###Director NIHR Leeds Biomedical Research Centre###University of Leeds###
Abstract Poster Presenter: Philip Conaghan, MD,PhD – University of Leeds
### 2101
LFD-200, an Antibody Drug Conjugate that Selectively Delivers a Glucocorticoid Payload to Immune Cells, Provides Sustained Anti-inflammatory Effects Without Systemic Toxicity in Non-human Primates (0494)

Matthew McClure, MD – Lifordi ### 2765269###Abstract Poster Presenter######Lifordi###
Abstract Poster Presenter: Matthew McClure, MD – Lifordi
### 0494
Libman-Sacks Endocarditis in APS: A Case-Control Study of Clinical and Serologic Features (0131)

Kyla Rodgers, MD, PhD – University of Michigan ### 2762795###Abstract Poster Presenter######University of Michigan###
Abstract Poster Presenter: Kyla Rodgers, MD, PhD – University of Michigan
### 0131
Lifestyle behaviours and disease activity in patients with psoriatic arthritis: the Dutch south west psoriatic arthritis study (2309)

Batoul Hojeij, n/a (she/her/hers) – Erasmus MC ### 2469246###Abstract Poster Presenter######Erasmus MC###
Abstract Poster Presenter: Batoul Hojeij, n/a (she/her/hers) – Erasmus MC
### she/her/hers 2309
Lifestyle Coaching in Psoriatic Arthritis: Pilot Findings from an Online eCoaching Program (0371)

Judy Zhang, BS, BA – Cleveland Clinic Lerner College of Medicine ### 2468895###Abstract Poster Presenter######Cleveland Clinic Lerner College of Medicine###
Abstract Poster Presenter: Judy Zhang, BS, BA – Cleveland Clinic Lerner College of Medicine
### 0371
Lighten the Load: Artificial Intelligence Reveals Body Mass Index Outranks Treatment in One-Year Psoriatic Arthritis Outcomes—Findings from the SPEED Trial (2340)

Alexander Garaiman, n/a – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK. ### 2766964###Abstract Poster Presenter######Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.###
Abstract Poster Presenter: Alexander Garaiman, n/a – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.
### 2340
Lightsheet imaging with 3D analysis for wholistic assessment of synovial lymphatic vasculature within joints of murine models of arthritis (1808)

Xi Lin, PhD – University of Rochester Medical Center ### 2118583###Abstract Poster Presenter######University of Rochester Medical Center###
Abstract Poster Presenter: Xi Lin, PhD – University of Rochester Medical Center
### 1808
Limited Concordance Between anti-dsDNA Assays and Association with Lupus Nephritis (1488)

Jessica Dai, BS – New York University Grossman School of Medicine ### 2766484###Abstract Poster Presenter######New York University Grossman School of Medicine###
Abstract Poster Presenter: Jessica Dai, BS – New York University Grossman School of Medicine
### 1488
Linezolid prevents fibroblast activation and ameliorates tissue fibrosis by inhibition of mitochondrial translation (0975)

Xuezhi Hong, MD – Department of Rheumatology, University Hospital Dusseldorf, Medical Faculty of Heinrich Heine University, Dusseldorf, Germany ### 2767970###Abstract Poster Presenter######Department of Rheumatology, University Hospital Dusseldorf, Medical Faculty of Heinrich Heine University, Dusseldorf, Germany###
Abstract Poster Presenter: Xuezhi Hong, MD – Department of Rheumatology, University Hospital Dusseldorf, Medical Faculty of Heinrich Heine University, Dusseldorf, Germany
### 0975
Linking PROMIS scores to disease severity and treatment in dermatomyositis: a patient-centered evaluation (2063)

Julie Paik, MD, MHS – Johns Hopkins University ### 850634###Abstract Poster Presenter######Johns Hopkins University###
Abstract Poster Presenter: Julie Paik, MD, MHS – Johns Hopkins University
### 2063
Lions, Tigers, and Bears, Oh my! (TM51)

Aaron Smith, MD, MS – University of North Carolina ### 2767907###Thieves Market Poster Presenter######University of North Carolina###
Thieves Market Poster Presenter: Aaron Smith, MD, MS – University of North Carolina
### TM51
Lipid Screening in Rheumatoid Arthritis: A Retrospective Cohort Study Highlighting Gaps in Cardiovascular Risk Prevention (0437)

Anokhi Saklecha, MD – Yale School of Medicine ### 2763248###Abstract Poster Presenter######Yale School of Medicine###
Abstract Poster Presenter: Anokhi Saklecha, MD – Yale School of Medicine
### 0437
Liver Biopsy Findings in Pediatric SLE: A Large Tertiary Center Experience (1296)

Meredith Rae, MD (she/her/hers) – Baylor College of Medicine/Texas Children's ### 1923135###Abstract Poster Presenter######Baylor College of Medicine/Texas Children's###
Abstract Poster Presenter: Meredith Rae, MD (she/her/hers) – Baylor College of Medicine/Texas Children's
### she/her/hers 1296
Living Well Despite the Challenges of Sjögren's Disease and Systemic Lupus Erythematous: My Perspective as a Health Care Provider and Patient (PP08)

Matt Makara, MPH – Sjogren's Foundation ### 2115446###Patient Poster Presenter######Sjogren's Foundation###
Patient Poster Presenter: Matt Makara, MPH – Sjogren's Foundation
### PP08
LMPTP Drives Fibrosis in Systemic Sclerosis via TGF-beta Signaling Activation (0976)

Yuan Zhan, n/a (she/her/hers) – Cedars-Sinai Medical Center ### 2768174###Abstract Poster Presenter######Cedars-Sinai Medical Center###
Abstract Poster Presenter: Yuan Zhan, n/a (she/her/hers) – Cedars-Sinai Medical Center
### she/her/hers 0976
Local Immune effector Cell-Associated Toxicity Syndrome (LICATS) in CAR T-cell treated patients with Autoimmune Disease (1537)

Melanie Hagen, MD (she/her/hers) – Department of Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg and Uniklinikum Erlangen ### 1428149###Abstract Poster Presenter######Department of Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg and Uniklinikum Erlangen###
Abstract Poster Presenter: Melanie Hagen, MD (she/her/hers) – Department of Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg and Uniklinikum Erlangen
### she/her/hers 1537
Longitudinal Analysis of B cell Remodeling in Systemic Lupus Erythematosus Following iPSC-Derived CAR T-cell Therapy (2454)

Trever Greene, PhD – Fate Therapeutics ### 2767727###Abstract Poster Presenter######Fate Therapeutics###
Abstract Poster Presenter: Trever Greene, PhD – Fate Therapeutics
### 2454
Longitudinal analysis on imaging outcomes: should we use the individual scores from multiple readers or rather the consensus or average of readers? (1958)

Liese de Bruin, MSc – Leiden University Medical Center ### 2112076###Abstract Poster Presenter######Leiden University Medical Center###
Abstract Poster Presenter: Liese de Bruin, MSc – Leiden University Medical Center
### 1958
Longitudinal assessment of circulating fibroblast activation protein in systemic sclerosis-associated interstitial lung disease (1560)

Bo Broens, MD – Amsterdam UMC ### 2767288###Abstract Poster Presenter######Amsterdam UMC###
Abstract Poster Presenter: Bo Broens, MD – Amsterdam UMC
### 1560
Longitudinal Clinical Response to JAK Inhibitors in Systemic Sclerosis: A Real-Life Multicentric Study Across Clinical Domains (1587)

Stefano Di Donato, MD – University of Leeds ### 2761706###Abstract Poster Presenter######University of Leeds###
Abstract Poster Presenter: Stefano Di Donato, MD – University of Leeds
### 1587
Longitudinal Disease Activity Trajectories in Patients with Systemic Lupus Erythematosus Treated with Belimumab (2447)

Fumin Qi, n/a – Tianjin Medical University General Hospital ### 2767941###Abstract Poster Presenter######Tianjin Medical University General Hospital###
Abstract Poster Presenter: Fumin Qi, n/a – Tianjin Medical University General Hospital
### 2447
Longitudinal Effectiveness of Abatacept in JIA: Results From an Ongoing JIA Registry (0401)

Daniel Lovell, MD, MPH – Cincinnati Children's Hospital Medical Center ### 1079685###Abstract Poster Presenter######Cincinnati Children's Hospital Medical Center###
Abstract Poster Presenter: Daniel Lovell, MD, MPH – Cincinnati Children's Hospital Medical Center
### 0401
Longitudinal Exploration of Pain and Disease Characteristics in Youth with Childhood-Onset Lupus (1289)

Jida Jaffan, MA – The Hospital for Sick Children/ University of Toronto ### 2471534###Abstract Poster Presenter######The Hospital for Sick Children/ University of Toronto###
Abstract Poster Presenter: Jida Jaffan, MA – The Hospital for Sick Children/ University of Toronto
### 1289
Longitudinal Exploration of Pain and Disease Characteristics in Youth with Childhood-Onset Lupus (1289)

Jida Jaffan, MA – The Hospital for Sick Children/ University of Toronto ### 2471534###Abstract Poster Presenter######The Hospital for Sick Children/ University of Toronto###
Abstract Poster Presenter: Jida Jaffan, MA – The Hospital for Sick Children/ University of Toronto
### 1289
Longitudinal Multiomic Study of Skin, Peripheral Blood, and Serum: Serum Proteome Reflects the Disease Process at the End-organ Level and Predicts the Course of Modified Rodnan Skin Score (0959)

Bich Na Choi, PhD – UT Health Houston ### 2767785###Abstract Poster Presenter######UT Health Houston###
Abstract Poster Presenter: Bich Na Choi, PhD – UT Health Houston
### 0959
Longitudinal Proteomic Effects of Hydroxychloroquine in Individuals at Risk of Lupus: Differential Signatures in Progressors and Non-Progressors (0023)

Benjamin Jones, BS – Oklahoma Medical Research Foundation ### 2114679###Abstract Poster Presenter######Oklahoma Medical Research Foundation###
Abstract Poster Presenter: Benjamin Jones, BS – Oklahoma Medical Research Foundation
### 0023
Longitudinal Serum Proteomic Profiles – A Step Closer to Personalized Monitoring in Dermatomyositis (0297)

Natasha Le Blanc, MD, BSc – McGill University ### 2763711###Abstract Poster Presenter######McGill University###
Abstract Poster Presenter: Natasha Le Blanc, MD, BSc – McGill University
### 0297
Longitudinal Trajectory Models to Assess Pain and Risk of Difficult-to-Treat Rheumatoid Arthritis (1644)

Misti Paudel, PhD, MPH – Brigham and Women's Hospital, Division of Rheumatology, Inflammation, and Immunity ### 2465314###Abstract Poster Presenter######Brigham and Women's Hospital, Division of Rheumatology, Inflammation, and Immunity###
Abstract Poster Presenter: Misti Paudel, PhD, MPH – Brigham and Women's Hospital, Division of Rheumatology, Inflammation, and Immunity
### 1644
Long-Term Cardiovascular Risk Following Tnfi vs Triple Therapy: A Post-hoc Analysis Integrating Randomized Clinical Trial and Electronic Health Record Data (2276)

Jennifer Hanberg, MD – Brigham and Women's Hospital ### 1079675###Abstract Poster Presenter######Brigham and Women's Hospital###
Abstract Poster Presenter: Jennifer Hanberg, MD – Brigham and Women's Hospital
### 2276
Long-Term Effects of Obinutuzumab on Kidney Function in Lupus Nephritis (1520)

Bahtiyar Toz, MD – Zucker School of Medicine at Hofstra/ Northwell ### 2768299###Abstract Poster Presenter######Zucker School of Medicine at Hofstra/ Northwell###
Abstract Poster Presenter: Bahtiyar Toz, MD – Zucker School of Medicine at Hofstra/ Northwell
### 1520
Long-Term Efficacy and Safety of Risankizumab for csDMARD-IR Patients With Active Psoriatic Arthritis: 244-Week Results From the KEEPsAKE 1 Trial (2362)

Mauro Keiserman, MD – Rheumatology Section, Pontifical Catholic University, School of Medicine ### 2111252###Abstract Poster Presenter######Rheumatology Section, Pontifical Catholic University, School of Medicine###
Abstract Poster Presenter: Mauro Keiserman, MD – Rheumatology Section, Pontifical Catholic University, School of Medicine
### 2362
Long-Term Efficacy and Safety of Tofacitinib in Active Axial Spondyloarthritis: Experience from a Tertiary Care Center in South India (0582)

Prabhu Vasantha Kumar, MD, DM – GKNM Hospitals & Research Institute, Coimbatore, Tamil Nadu, India ### 2466611###Abstract Poster Presenter######GKNM Hospitals & Research Institute, Coimbatore, Tamil Nadu, India###
Abstract Poster Presenter: Prabhu Vasantha Kumar, MD, DM – GKNM Hospitals & Research Institute, Coimbatore, Tamil Nadu, India
### 0582
Long-term efficacy of intra-articular triamcinolone hexacetonide injections in juvenile idiopathic arthritis patients starting tumor necrosis factor inhibitor therapy: 48 weeks results from a randomized, open-label, blinded-assessor multicenter phase 4 trial - the MyJIA trial (0420)

Pernille Bøyesen, MD, PhD – Oslo University Hospital ### 2765017###Abstract Poster Presenter######Oslo University Hospital###
Abstract Poster Presenter: Pernille Bøyesen, MD, PhD – Oslo University Hospital
### 0420
Long-term impact of secukinumab on the prevention of psoriatic arthritis in patients with psoriasis: a 5-year pooled analysis of the ERASURE, FIXTURE and SCULPTURE studies (1447)

Laura Coates, MD, PhD – University of Oxford ### 684518###Abstract Poster Presenter###Associate Professor###University of Oxford###
Abstract Poster Presenter: Laura Coates, MD, PhD – University of Oxford
### 1447
Long-Term Outcomes in Systemic Lupus Erythematosus Patients Infected with SARS-CoV-2: Variant-Specific Analysis of Pre-Delta/Delta and Omicron Periods (1493)

Lilliana Serrano Arroyo, MD, MPH – University of Puerto Rico Medical Sciences Campus ### 2110753###Abstract Poster Presenter######University of Puerto Rico Medical Sciences Campus###
Abstract Poster Presenter: Lilliana Serrano Arroyo, MD, MPH – University of Puerto Rico Medical Sciences Campus
### 1493
Long-Term Prevention of RA in high-risk individuals after a 6-Month Placebo-Controlled Intervention with Abatacept -The ARIAA Trial (2279)

Koray Tascilar, MD – Friedrich Alexander University of Erlangen Nuremberg, Universitätsklinikum Erlangen Department of Medicine-3 Rheumatology and Immunology ### 1421227###Abstract Poster Presenter######Friedrich Alexander University of Erlangen Nuremberg, Universitätsklinikum Erlangen Department of Medicine-3 Rheumatology and Immunology###
Abstract Poster Presenter: Koray Tascilar, MD – Friedrich Alexander University of Erlangen Nuremberg, Universitätsklinikum Erlangen Department of Medicine-3 Rheumatology and Immunology
### 2279
Long-term Radiographic Progression in Early versus Established Axial Spondyloarthritis: A 12-Year Observational Study (1432)

Tae-jong Kim, MD, PhD – Department of Rheumatology, Chonnam National University Medical School and Hospital ### 2108674###Abstract Poster Presenter######Department of Rheumatology, Chonnam National University Medical School and Hospital###
Abstract Poster Presenter: Tae-jong Kim, MD, PhD – Department of Rheumatology, Chonnam National University Medical School and Hospital
### 1432
Long-Term Safety and Efficacy of Upadacitinib in Patients With Psoriatic Arthritis: 5-Year Results From the Phase 3 SELECT-PsA 1 Study (1443)

Iain McInnes, PhD, FRCP – University of Glasgow ### 684432###Abstract Poster Presenter###Professor of Medicine and Rheumatology###University of Glasgow###
Abstract Poster Presenter: Iain McInnes, PhD, FRCP – University of Glasgow
### 1443
Long-Term Safety and Tolerability of Bimekizumab Treatment Across Phase 2b and Phase 3 Studies in Patients with Axial Spondyloarthritis or Psoriatic Arthritis: 3-Year Update from the Phase 3 Studies (1454)

Philip Mease, MD – Swedish Medical Center/Providence St. Joseph Health ### 767420###Abstract Poster Presenter###Rheumatologist, Director of Rheumatology Research, Clinical Professor Director of Rheumatology Research Swedish Medical Center/Providence-St Joseph Health ###Swedish Medical Center/Providence St. Joseph Health###
Abstract Poster Presenter: Philip Mease, MD – Swedish Medical Center/Providence St. Joseph Health
### 1454
Long-Term Safety of Tildrakizumab Through Week 208 in Patients With Psoriatic Arthritis: Results From the Phase 2b Open-Label Extension Study (1456)

Philip Mease, MD – Swedish Medical Center/Providence St. Joseph Health ### 767420###Abstract Poster Presenter###Rheumatologist, Director of Rheumatology Research, Clinical Professor Director of Rheumatology Research Swedish Medical Center/Providence-St Joseph Health ###Swedish Medical Center/Providence St. Joseph Health###
Abstract Poster Presenter: Philip Mease, MD – Swedish Medical Center/Providence St. Joseph Health
### 1456
Long-Term Uveitis Rates with Bimekizumab Treatment Across Pooled Phase 2b and Phase 3 Studies in Patients with Axial Spondyloarthritis or Psoriatic Arthritis: 3-Year Update (2352)

Irene van der Horst-Bruinsma, MD, PhD – Radboud umc ### 2109110###Abstract Poster Presenter######Radboud umc###
Abstract Poster Presenter: Irene van der Horst-Bruinsma, MD, PhD – Radboud umc
### 2352
Loss of MicroRNA29 expression in B cells and skin microbiota synergize to promote atopic dermatitis in mice. (0909)

Marcus Hines, MD;PhD – New York University Grossman School of Medicine ### 2763184###Abstract Poster Presenter######New York University Grossman School of Medicine###
Abstract Poster Presenter: Marcus Hines, MD;PhD – New York University Grossman School of Medicine
### 0909
Low 25-hydroxyvitamin D Levels are Associated with Higher Mortality and More Cardiovascular Events in Systemic Lupus Erythematosus (0597)

Michelle Petri, MD, MPH (she/her/hers) – Johns Hopkins University School of Medicine ### 684562###Abstract Poster Presenter######Johns Hopkins University School of Medicine###
Abstract Poster Presenter: Michelle Petri, MD, MPH (she/her/hers) – Johns Hopkins University School of Medicine
### she/her/hers 0597
Low Disease Activity: Good Enough? (0444)

Emily Thoman, DO – Lankenau Medical Center ### 2764982###Abstract Poster Presenter######Lankenau Medical Center###
Abstract Poster Presenter: Emily Thoman, DO – Lankenau Medical Center
### 0444
Low-Dose Aspirin Therapy in Patients with Type 2 Diabetes and Systemic Lupus Erythematosus: A Propensity-Matched Cohort Study (1543)

Sila Mateo Faxas, MD (she/her/hers) – Good Samaritan Hospital ### 2762898###Abstract Poster Presenter######Good Samaritan Hospital###
Abstract Poster Presenter: Sila Mateo Faxas, MD (she/her/hers) – Good Samaritan Hospital
### she/her/hers 1543
Low-dose belimumab reduced disease flares in patients with systemic lupus erythematosus at low disease activity: a multicenter, randomized, double-blind, placebo-controlled trial (0656)

Fangfang Sun, MD – Renji Hospital ### 2767767###Abstract Poster Presenter######Renji Hospital###
Abstract Poster Presenter: Fangfang Sun, MD – Renji Hospital
### 0656
Low-Dose CT reveals syndesmophyte progression in axial SpA, particularly in the thoracic spine: Insights from the SPACE cohort covering early and established disease (0540)

Manouk de Hooge, PhD – Ghent University Hospital & Leiden University Medical Center ### 1424968###Abstract Poster Presenter######Ghent University Hospital & Leiden University Medical Center###
Abstract Poster Presenter: Manouk de Hooge, PhD – Ghent University Hospital & Leiden University Medical Center
### 0540
L-sepiapterin treatment reduces renal cortical gene expression associated with oxidative stress and fibrosis in NZM2410 murine lupus nephritis (0944)

Jim Oates, MD – Medical University of South Carolina ### 1421018###Abstract Poster Presenter######Medical University of South Carolina###
Abstract Poster Presenter: Jim Oates, MD – Medical University of South Carolina
### 0944
Lumps, Bumps, and Diagnostic Stumps (TM61)

Michael Miller, MD – University of Iowa Hospitals and Clinics ### 2795810###Thieves Market Poster Presenter######University of Iowa Hospitals and Clinics###
Thieves Market Poster Presenter: Michael Miller, MD – University of Iowa Hospitals and Clinics
### TM61
Lung Cancer Screening with Rheumatoid Arthritis: A Retrospective Claims Analysis (1920)

Huifang Lu, MD;PhD – UT MD Anderson Cancer Center ### 2112183###Abstract Poster Presenter######UT MD Anderson Cancer Center###
Abstract Poster Presenter: Huifang Lu, MD;PhD – UT MD Anderson Cancer Center
### 1920
Lung Transplant Outcomes in Patients with Myositis- and Systemic Sclerosis-Associated Interstitial Lung Disease Compared to Idiopathic Pulmonary Fibrosis: A Multicentric Retrospective Analysis (1193)

Angela Chang, MD – University of British Columbia ### 2763330###Abstract Poster Presenter######University of British Columbia###
Abstract Poster Presenter: Angela Chang, MD – University of British Columbia
### 1193
Lung Transplant Outcomes in Patients with Rheumatoid Arthritis Associated Interstitial Lung Disease Compared to Idiopathic Pulmonary Fibrosis: A Multicentric Retrospective Analysis and Meta-analysis (2259)

Saud AlHajeri, MBChB – UBC ### 2765627###Abstract Poster Presenter######UBC###
Abstract Poster Presenter: Saud AlHajeri, MBChB – UBC
### 2259
Lung Transplantation Outcomes for Pulmonary Sarcoidosis Compared to Idiopathic Pulmonary Fibrosis: A Single Institution Multisite Experience (1255)

Reena Yaman, MD, MS, BSc (she/her/hers) – Mayo Clinic Florida ### 2764423###Abstract Poster Presenter######Mayo Clinic Florida###
Abstract Poster Presenter: Reena Yaman, MD, MS, BSc (she/her/hers) – Mayo Clinic Florida
### she/her/hers 1255
Lung Vasculature Quantification on Computed Tomography Predicts New Onset of Interstitial Lung Disease in Systemic Sclerosis (1580)

Maria Iacovantuono, MD – Rheumatology, Allergology and Clinical Immunology, Department of Systems Medicine, Tor Vergata University, Rome, Italy ### 2767355###Abstract Poster Presenter######Rheumatology, Allergology and Clinical Immunology, Department of Systems Medicine, Tor Vergata University, Rome, Italy###
Abstract Poster Presenter: Maria Iacovantuono, MD – Rheumatology, Allergology and Clinical Immunology, Department of Systems Medicine, Tor Vergata University, Rome, Italy
### 1580
Lupus Damage Index Revision – Item Generation and Reduction Phases (2387)

Burak Kundakci, PhD, MSc – University of Manchester ### 1760664###Abstract Poster Presenter######University of Manchester###
Abstract Poster Presenter: Burak Kundakci, PhD, MSc – University of Manchester
### 2387
Lupus Disease Activity Adversely Affects the Quality of Life but not Intimate Relationship and Sexual Function in Indian Female Lupus Patients (1503)

Ranjan Gupta, MD, DM (he/him/his) – All India Institute of Medical Sciences ### 2108707###Abstract Poster Presenter######All India Institute of Medical Sciences###
Abstract Poster Presenter: Ranjan Gupta, MD, DM (he/him/his) – All India Institute of Medical Sciences
### he/him/his 1503
Lupus Intervention Fatigue Trial: Preliminary Analysis of Baseline Data (2455)

Justin Arnold, BA (he/him/his) – Northwestern Feinberg School of Medicine ### 2767794###Abstract Poster Presenter######Northwestern Feinberg School of Medicine###
Abstract Poster Presenter: Justin Arnold, BA (he/him/his) – Northwestern Feinberg School of Medicine
### he/him/his 2455
Lupus Nephritis Clinical Practice Guidelines: Critical Appraisal and Quality Comparison Using the AGREE II Tool (1527)

Egla Sanchez-Peralta, MS (she/her/hers) – Universidad Autonoma de Nuevo Leon ### 2761380###Abstract Poster Presenter######Universidad Autonoma de Nuevo Leon###
Abstract Poster Presenter: Egla Sanchez-Peralta, MS (she/her/hers) – Universidad Autonoma de Nuevo Leon
### she/her/hers 1527
Lupus Patient Navigator Program for Improving Care Adherence for Minority Patients (1082)

Rashi Vora, MD – Medical University of South Carolina ### 2762214###Abstract Poster Presenter######Medical University of South Carolina###
Abstract Poster Presenter: Rashi Vora, MD – Medical University of South Carolina
### 1082
Lupus Skin Shapes a Distinct Inflammatory Milieu that Drives the Skewing of Treg and inflammatory T cells (0985)

Hiroshi Kato, MD (he/him/his) – Michigan Medicine ### 2473309###Abstract Poster Presenter######Michigan Medicine###
Abstract Poster Presenter: Hiroshi Kato, MD (he/him/his) – Michigan Medicine
### he/him/his 0985
Lupus Under the Lens: Fibrinogen-to-Albumin Ratio as a Novel Inflammatory Index (1485)

Guru Vijay Chagalakondu, DM – Employee State Insurance Corporation (ESIC) ### 2766576###Abstract Poster Presenter######Employee State Insurance Corporation (ESIC)###
Abstract Poster Presenter: Guru Vijay Chagalakondu, DM – Employee State Insurance Corporation (ESIC)
### 1485